A drug that targets the immune system can delay Type 1 diabetes on average by two years in children and adults at high risk, according to findings from TrialNet’s Teplizumab (anti-CD3) Prevention Study in the US. Type 1 diabetes occurs when the body’s read more »

As part of our research to find the cure for Type 1 diabetes, JDRF is working to develop techniques that will one day allow people to regain insulin-producing beta cells. ViaCyte visualisation. In Type 1 diabetes, the beta cells are killed off by the read more »

A free Type 1 Technology Discovery Evening is being held in York where you can find out more about the latest progress in Type 1 diabetes research and technology, listen to inspirational talks, and meet others affected by the condition. The event, organised read more »

For Diabetes Week (10 to 16 June) charity JDRF is focusing on how a lack of understanding of Type 1 diabetes has led to myths and misconceptions, which can impact on emotional wellbeing for people living with the condition. It will be read more »

Diabetes charities call on the government to provide concrete detail on access to insulin in the event of no-deal Brexit. In a joint statement, Diabetes UK and JDRF have said that, without more detail, they cannot say a no-deal Brexit will be read more »

Taking place on 1st June 2019 in Birmingham, this is an event for adults with T1D to chat with people with similar interests, listen to talks and exchange ideas. The day will include an opening address by actor/comedian Jon-Sel Gourkan and a talk read more »

With five times the population and ten times the cases of diabetes, what goes on in the US is often of interest, sometimes leading to impact in the UK too, eventually. Here is a recent round up of some interesting news items read more »

In her 40th ‘diaversary’ story, Karen Addington, CEO of JDRF UK, looks back at her life since diagnosis with Type 1 diabetes. She says, “This diagnosis story is my attempt to explain why I work in the field of Type 1 diabetes research. read more »

An update on the closed-loop insulin delivery system being funded by JDRF to treat Type 1 diabetes, by Rebecca Leitch, who works at JDRF UK. In our mission to help people with Type 1 diabetes lead better, safer, healthier lives until we ultimately read more »

Commenting on news stories about the possibility of medical supplies being jeopardized by the looming decision about Britain leaving the EU, JDRF has affirmed that it is committed to ensuring that the needs of people with Type 1 diabetes are taken into read more »